IceCure Medical Ltd
ICCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,291 | $3,229 | $3,085 | $4,138 |
| % Growth | 1.9% | 4.7% | -25.4% | – |
| Cost of Goods Sold | $1,840 | $1,929 | $1,640 | $1,943 |
| Gross Profit | $1,451 | $1,300 | $1,445 | $2,195 |
| % Margin | 44.1% | 40.3% | 46.8% | 53% |
| R&D Expenses | $7,096 | $8,273 | $9,123 | $5,877 |
| G&A Expenses | $8,912 | $4,166 | $5,857 | $4,125 |
| SG&A Expenses | $10,051 | $8,603 | $9,061 | $6,042 |
| Sales & Mktg Exp. | $1,139 | $4,437 | $3,204 | $1,917 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17,147 | $16,876 | $18,184 | $11,919 |
| Operating Income | -$15,696 | -$15,576 | -$16,739 | -$9,724 |
| % Margin | -476.9% | -482.4% | -542.6% | -235% |
| Other Income/Exp. Net | $378 | $924 | -$239 | -$171 |
| Pre-Tax Income | -$15,318 | -$14,652 | -$16,978 | -$9,895 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15,318 | -$14,652 | -$17,217 | -$10,066 |
| % Margin | -465.5% | -453.8% | -558.1% | -243.3% |
| EPS | -0.3 | -0.32 | -0.47 | -0.35 |
| % Growth | 6.3% | 31.9% | -34.3% | – |
| EPS Diluted | -0.3 | -0.32 | -0.47 | -0.35 |
| Weighted Avg Shares Out | 50,877 | 45,638 | 37,017 | 28,549 |
| Weighted Avg Shares Out Dil | 50,877 | 45,638 | 37,017 | 28,549 |
| Supplemental Information | – | – | – | – |
| Interest Income | $378 | $924 | $0 | $0 |
| Interest Expense | $0 | $0 | $239 | $171 |
| Depreciation & Amortization | $332 | $323 | $248 | $127 |
| EBITDA | -$15,364 | -$15,253 | -$16,491 | -$9,597 |
| % Margin | -466.8% | -472.4% | -534.6% | -231.9% |